Trial Profile
A retrospective study of Intravitreal bevacizumab for diabetic macular oedema: Pan-American Collaborative Retina Study group
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 03 Jul 2017 New trial record